Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Faivre S, Santoro A, Kelley RK, Gane E, Costentin CE, Gueorguieva I, Smith C, Cleverly A, Lahn MM, Raymond E, Benhadji KA, Giannelli G

Publication

Liver international : official journal of the International Association for the Study of the Liver

Publication ID (Profile URL)

https://researcherprofiles.org/profile/57841078

Publication Year

2019

PubMed ID

30963691

Publication Title

Faivre S, Santoro A, Kelley RK, Gane E, Costentin CE, Gueorguieva I, Smith C, Cleverly A, Lahn MM, Raymond E, Benhadji KA, Giannelli G. Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma. Liver Int. 2019 08; 39(8):1468-1477.